Pharming Group NV (PHAR)

Currency in EUR
1.152
+0.006(+0.52%)
Real-time Data·

PHAR Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy

Technical Indicators

Strong Buy

Moving Averages

Neutral

Summary:Buy

Moving Averages:NeutralBuy: (6)Sell: (6)
Technical Indicators:Strong BuyBuy: (7)Sell: (1)

Technical Indicators

Summary: Strong BuyBuy: 7Neutral: 1Sell: 1
Jul 20, 2026 12:52 GMT
Name
Value
Action
RSI(14)50.147Neutral
STOCH(9,6)79.031Buy
STOCHRSI(14)100Overbought
MACD(12,26)-0.003Sell
ADX(14)36.273Buy
Williams %R-6.154Overbought
CCI(14)102.2975Buy
ATR(14)0.0071Less Volatility
Highs/Lows(14)0.0067Buy
Ultimate Oscillator55.682Buy
ROC1.45Buy
Bull/Bear Power(13)0.0075Buy

Moving Averages

Summary: NeutralBuy: 6Sell: 6
Jul 20, 2026 12:52 GMT
Name
Simple
Exponential
MA5
1.151
Buy
1.152
Buy
MA10
1.149
Buy
1.150
Buy
MA20
1.148
Buy
1.151
Buy
MA50
1.162
Sell
1.168
Sell
MA100
1.202
Sell
1.179
Sell
MA200
1.185
Sell
1.178
Sell

Pivot Points

Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic1.1441.1461.151.1521.1561.1581.162
Fibonacci1.1461.1481.151.1521.1541.1561.158
Camarilla1.1521.1531.1531.1521.1551.1551.156
Woodie's1.1461.1471.1521.1531.1581.1591.164
DeMark's--1.1511.1531.157--

FAQ

From a Technical Analysis Perspective, Is Pharming Group a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Do the Moving Averages for PHAR Currently Stand?

The moving averages for Pharming Group show a Strong Sell outlook, considering moving averages ranging from MA5 to MA200, with 1 Buy signals and 11 Sell signals.

What Is the Current Status of the Technical Indicators for Pharming Group?

The technical indicators for Pharming Group are in a Strong Sell position based on daily analysis, with 1 signals on buy indicators and 9 sell signals.

What Is PHAR's 14-Day RSI?

The current Relative Strength Index (RSI) of PHAR over the 14-day period is 50.147, which suggests that the stock is a Neutral.

What Is PHAR's MACD?

PHAR's MACD is -0.003, which suggests that the stock is a Sell.

What Is PHAR's 5-Day Moving Average?

PHAR's 5-day moving average is 1.151, suggesting that the stock is a Buy.

What Is PHAR's 50-Day Moving Average?

PHAR's 50-day moving average is 1.162, suggesting that the stock is a Sell.

What Is PHAR's 200-Day Moving Average?

PHAR's 200-day moving average is 1.185, suggesting that the stock is a Sell.

What Is the Fibonacci Pivot Point Performance Value for PHAR?

The Fibonacci pivot point performance value for PHAR is 1.152.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.